Product Overview: Atorlip
Atorlip 20 mg is a pharmaceutical preparation containing atorvastatin calcium, a synthetic HMG-CoA reductase inhibitor extensively studied in cardiovascular research applications. This Cipla-manufactured compound represents a critical tool for investigating cholesterol biosynthesis pathways and lipid metabolism mechanisms in controlled laboratory environments. Research scientists at Stroid UK Shop frequently examine atorvastatin’s molecular interactions with 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis pathways.
Laboratory Research Applications
Investigators utilise atorvastatin in diverse experimental protocols examining lipid metabolism modulation and pleiotropic cardiovascular effects. Research models evaluate this compound’s inhibitory mechanisms on cholesterol synthesis while examining secondary effects on C-reactive protein expression, nitric oxide bioavailability, and endothelial function markers. Studies within hypolipidemic research frameworks analyse atorvastatin’s impact on inflammatory pathways and oxidative stress biomarkers. Comparative analyses often examine interactions with selective androgen receptor modulators and bioactive peptides in metabolic research contexts, investigating potential synergistic mechanisms affecting lipid profiles and cellular energy expenditure pathways.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Atorvastatin Calcium |
| Concentration | 20mg per tablet |
| Manufacturer | Cipla Limited |
| CAS Number | 134523-00-5 |
| Molecular Formula | C₃₃H₃₄FN₂O₅·Ca²⁺ |
| Storage Conditions | Room temperature, dry environment |
| Purity Grade | Pharmaceutical standard |
| Research Applications | Cholesterol synthesis inhibition studies |
Regulatory Compliance Statement
This atorvastatin preparation is supplied exclusively for in-vitro research purposes and laboratory investigations. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this compound. All experimental work should comply with institutional guidelines for pharmaceutical research materials.
